Data Insights
By Company Name
No filters selected
By Disease Name
No filters selected
By Drug Name
No filters selected
By Themes
No filters selected
Showing 1 results out of 1
Data Insights
ICTCAR-028 by Innovative Cellular Therapeutics for Hematological Tumor: Likelihood of Approval
ICTCAR-028 is under clinical development by Innovative Cellular Therapeutics and currently in Phase III for Hematological Tumor. According to GlobalData,...